Low Tregs: A targetable risk factor for life-threatening cardiovascular complications after major noncardiac surgery.
Discussion on Tregs that have anti-inflammatory and anti-atherogenic properties as an ideal therapeutic target to reduce fatal cardiovascular deaths following major noncardiac surgery.